At the end of last year, I noted that CFDA’s proposed new Drug Registration Rule could spell the end of China’s limited patent linkage regime. A new public comment draft of the […]
At the end of last year, I noted that CFDA’s proposed new Drug Registration Rule could spell the end of China’s limited patent linkage regime. A new public comment draft of the […]